SEC Contract Filing

Filing Date: 2016-03-22

Document Content:
<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>2
<FILENAME>a2227816zex-10_39.htm
<DESCRIPTION>EX-10.39
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#15ZCW16401_2">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"Black" -->

<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->

<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->

<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->

<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->

<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->

<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->

</FONT></P>

<!-- TOC_END -->
<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><A
NAME="kc16401_exhibit_10.39"> </A>
<A NAME="toc_kc16401_1"> </A>
<BR></FONT><FONT SIZE=2><B> Exhibit&nbsp;10.39 <BR> </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="kc16401_amendment_n0._1_to_dipexium_ph__ame02569"> </A>
<A NAME="toc_kc16401_2"> </A></FONT> <FONT SIZE=2><B> AMENDMENT N0. 1<BR> TO<BR> DIPEXIUM PHARMACEUTICALS,&nbsp;INC. 2013 EQUITY INCENTIVE PLAN <BR> </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Section&nbsp;14 of the 2013 Equity Incentive Plan (the </FONT><FONT SIZE=2><B>"Plan")</B></FONT><FONT SIZE=2> of
Dipexium Pharmaceuticals,&nbsp;Inc. (the </FONT><FONT SIZE=2><B>"Company"),</B></FONT><FONT SIZE=2> the Board of Directors of the Company has duly adopted a resolution, conditioned upon approval by
the stockholders of the Company, approving this Amendment No.&nbsp;1 to the Plan to increase the total number of shares of common stock, par value $.001 per share, of the Company (the </FONT> <FONT SIZE=2><B>"Common Stock")</B></FONT><FONT SIZE=2>
reserved and available for issuance under the Plan as follows: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5(b)
of the Plan is hereby amended to read in its entirety as follows: </FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>"(b)
Subject to Sections&nbsp;3, 11 and 12 of this Plan, the Committee is authorized to deliver under this Plan an aggregate of Two Million One Hundred Forty One Thousand One Hundred Sixty Nine
(2,141,169) Common Shares, and the maximum aggregate number of Shares that may be granted in the form of Incentive Stock Options is 2,141,169. Each Common Share subject to an Option or a Stock
Appreciation Right will reduce the number of Common Shares available for issuance by one share, and each Common Share underlying an Award of Restricted Stock, Restricted Stock Units, Stock Bonus
Awards and Performance Compensation Awards will reduce the number of Common Shares available for issuance by 1.15 shares." </FONT></P>

</UL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
other terms and provisions of the Plan shall remain unchanged and in full force and effect as written. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
majority in voting interest of the stockholders present in person or by proxy and entitled to vote at the meeting of stockholders at which this Amendment No.&nbsp;1
was considered, has duly approved this Amendment No.&nbsp;1 to the Plan. </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>IN WITNESS WHEREOF,</B></FONT><FONT SIZE=2> this Amendment No.&nbsp;1 to the Plan is made effective this 22<SUP>th</SUP>&nbsp;day of March, 2015. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2>DIPEXIUM PHARMACEUTICALS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2><BR>
 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;DAVID P. LUCI<BR>

<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Name:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:time